Operating Lease, Right-of-Use Asset of Arcadia Biosciences, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arcadia Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Arcadia Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Arcadia Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$306,000 -100% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $10,000 -$503,000 -98% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $19,000 -$676,000 -97% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $137,000 -$655,000 -83% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $306,000 -$841,000 -73% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $513,000 -$871,000 -63% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $695,000 -$923,000 -57% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $792,000 -$1,056,000 -57% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 $1,147,000 -$926,000 -45% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,384,000 -$924,000 -40% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $1,618,000 -$928,000 -36% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $1,848,000 -$1,233,000 -40% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $2,073,000 -$1,413,000 -41% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $2,308,000 -$4,052,000 -64% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $2,546,000 -$3,090,000 -55% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $3,081,000 -$2,745,000 -47% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $3,486,000 -$2,527,000 -42% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $6,360,000 +$762,000 +14% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $5,636,000 -$18,000 -0.32% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $5,826,000 +$3,863,000 +197% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $6,013,000 +$4,102,000 +215% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $5,598,000 +$3,547,000 +173% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $5,654,000 +$3,461,000 +158% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $1,963,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $1,911,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $2,051,000 30 Jun 2019 10-Q 06 Nov 2019 2019 Q3
Q1 2019 $2,193,000 31 Mar 2019 10-Q 06 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.